ClassID:

21216

A61K2039/6037 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen; Proteins Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Recent Application in this class:
#601
20140037641
2014-02-06

Peptide and conjugate vaccines for fungal infections

#602
20140037633
2014-02-06

Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides

#603
20140030287
2014-01-30

Enolase peptide conjugate vaccines against

#604
20140017271
2014-01-16

Immunogenic compositions of antigens

#605
20140005366
2014-01-02

Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies

#606
20130344103
2013-12-26

Conjugation process

#607
20130315960
2013-11-28

Conjugated β-1,3-linked glucans

#608
20130309179
2013-11-21

Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with

#609
20130295132
2013-11-07

Conjugation of streptococcal capsular saccharides

#610
20130287804
2013-10-31

Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide

#611
20130280293
2013-10-24

Combination heptavalent vaccine

#612
20130224798
2013-08-29

Methods of making hemagglutinin proteins

#613
20130209503
2013-08-15

Method for stabilization of biological molecules

#614
20130196352
2013-08-01

Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines

#615
20130195907
2013-08-01

OMV vaccines

#616
20130189300
2013-07-25

Conjugates comprising an antigen and a carrier molecule

#617
20130156802
2013-06-20

Cholera toxin chimera and its use as a staph vaccine

#618
20130136763
2013-05-30

Methods of treatment with compositions that include hemagglutinin

#619
20130122040
2013-05-16

Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use

#620
20130115237
2013-05-09

THERAPEUTIC IMMUNIZATION IN HIV INFECTED SUBJECTS TO AUGMENT ANTIRETROVIRAL TREATMENT

#621
20130084306
2013-04-04

Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules

#622
20130071428
2013-03-21

Peptides, conjugates and method for increasing immunogenicity of a vaccine

#623
20130071424
2013-03-21

Peptides mimicking HIV-1 viral epitopes in the V2 loop for the GP120 surface envelope glycoprotein

#624
20130064841
2013-03-14

Immunogenic compositions against human progastrin peptides

#625
20130058969
2013-03-07

Chloroplasts engineered to express pharmaceutical proteins

#626
20130058869
2013-03-07

Prevention And Treatment Of Amyloidogenic Disease

#627
20130052204
2013-02-28

(POLY)-GLYCEROLPHOSPHATE-BASED ANTI-GRAM POSITIVE BACTERIAL VACCINE

#628
20130034580
2013-02-07

Formulations which stabilize and inhibit precipitation of immunogenic compositions

#629
20130022634
2013-01-24

Mutant CTAI fusion protein for treatment of allergy and autoimmune disease

#630
20130022628
2013-01-24

ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM

#631
20130011430
2013-01-10

HUMAN CHORIONIC GONADOTROPIN (hCG) BASED VACCINE FOR PREVENTION AND TREATMENT OF CANCER

#632
20130005030
2013-01-03

Nucleic acids encoding GAS57 mutant antigens

#633
20130004532
2013-01-03

Process for manufacturing vaccines

#634
20120328646
2012-12-27

Globo H and related anti-cancer vaccines with novel glycolipid adjuvants

#635
20120328639
2012-12-27

Immunogenic LHRH compositions and methods relating thereto

#636
20120328605
2012-12-27

COMPOSITIONS AND USES

#637
20120321694
2012-12-20

COMPOSITIONS AND USES

#638
20120321660
2012-12-20

Conjugation process of bacterial polysaccharides to carrier proteins

#639
20120321658
2012-12-20

IMMUNOGENIC COMPOSITION COMPRISING S. PNEUMONIAE POLYSACCHARIDES CONJUGATED TO CARRIER PROTEINS

#640
20120301502
2012-11-29

15-VALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE VACCINE COMPOSITION

#641
20120301481
2012-11-29

Targeting poly-gama-glutamic acid to treat and related infections

#642
20120301480
2012-11-29

lipopolysaccharide outer core epitope

#643
20120282295
2012-11-08

Purification of type 5 capsular saccharides

#644
20120276140
2012-11-01

Compositions and methods for activating innate and allergic immunity

#645
20120276137
2012-11-01

Compositions and methods for preparing serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions

#646
20120276116
2012-11-01

Prevention and Treatment of Amyloidogenic Disease

#647
20120276107
2012-11-01

Methods and compositions for mycoplasma pneumoniae exotoxins

#648
20120269836
2012-10-25

Vaccine

#649
20120237549
2012-09-20

Conjugation of type 5 and type 8 capsular polysaccharides

#650
20120237542
2012-09-20

Multivalent pneumococcal polysaccharide-protein conjugate composition

#651
20120219560
2012-08-30

De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

#652
20120214206
2012-08-23

Vectors for molecule delivery to CD11b expressing cells

#653
20120207780
2012-08-16

Vaccine composition

#654
20120201841
2012-08-09

POLYPEPTIDES AND POLYNUCLEOTIDES FOR ENHANCING IMMUNE REACTIVITY TO HER-2 PROTEIN

#655
20120195962
2012-08-02

Multiepitope vaccine for Her2/neu-associated cancers

#656
20120195937
2012-08-02

POLYANIONIC POLYMER ADJUVANTS FOR HAEMOPHILUS INFLUENZAE B SACCHARIDE VACCINES

#657
20120195926
2012-08-02

METHODS OF IMPROVING VACCINE IMMUNOGENICITY

#658
20120195922
2012-08-02

Methods for preparing complex multivalent immunogenic conjugates

#659
20120189572
2012-07-26

Vaccine targeting cellular death receptor DR5

#660
20120164145
2012-06-28

lipopolysaccharide outer core epitope

#661
20120148621
2012-06-14

Methods and compositions for promoting a cell-mediated immune response

#662
20120135038
2012-05-31

EXPRESSION OF PROTECTIVE ANTIGENS IN TRANSGENIC CHLOROPLASTS AND THE PRODUCTION OF IMPROVED VACCINES

#663
20120121633
2012-05-17

HIV CD4 BINDING SITE BASED COVALENT IMMUNOGEN COMPOSITIONS

#664
20120114685
2012-05-10

Compositions comprising angiogenic factors and methods of use thereof

#665
20120107345
2012-05-03

Manufacture of vaccines that contain both hepatitis B virus surface antigens and surfactant

#666
20120107327
2012-05-03

Immunogenic compositions of antigens

#667
20120100172
2012-04-26

IMMUNOGENIC STREPTOCOCCUS PNEUMONIAE PEPTIDES AND PEPTIDE-MULTIMERS

#668
20120100165
2012-04-26

Drug transporter, and adjuvant and vaccine each utilizing same

#669
20120087939
2012-04-12

Methods and compositions for treating and preventing Shiga toxin-producing infection

#670
20120076817
2012-03-29

Polysaccharide-protein conjugate vaccines

#671
20120076780
2012-03-29

Recombinant fusion protein and polynucleotide construct for immunotoxin production

#672
20120070493
2012-03-22

TARGETED MULTI-EPITOPE DOSAGE FORMS FOR INDUCTION OF AN IMMUNE RESPONSE TO ANTIGENS

#673
20120064103
2012-03-15

COMBINATIONS OF MENINGOCOCCAL FACTOR H BINDING PROTEIN AND PNEUMOCOCCAL SACCHARIDE CONJUGATES

#674
20120052088
2012-03-01

PNEUMOCOCCAL VACCINE AND USES THEREOF

#675
20120021002
2012-01-26

Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof

#676
20120020993
2012-01-26

Vaccine

#677
20120010398
2012-01-12

Purification method

#678
20110318381
2011-12-29

Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction

#679
20110318348
2011-12-29

INDUCTION OF MUCOSAL IMMUNE RESPONSES BY MUCOSAL DELIVERY PENTABODY COMPLEX (MDPC)

#680
20110311576
2011-12-22

MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH NON-HIB VACCINES

#681
20110311575
2011-12-22

Mixing lyophilised meningococcal vaccines with D-T-Pa vaccines

#682
20110306756
2011-12-15

Prevention and Treatment of Amyloidogenic Disease

#683
20110300174
2011-12-08

Conjugates for the prevention or treatment of nicotine addiction

#684
20110300173
2011-12-08

Capsule composition for use as immunogen against

#685
20110300163
2011-12-08

IgE CH3 peptide vaccine

#686
20110293647
2011-12-01

IMMUNOGENIC LHRH COMPOSITIONS AND METHODS RELATING THERETO

#687
20110287049
2011-11-24

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES

#688
20110287037
2011-11-24

Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof

#689
20110282036
2011-11-17

BSA-specific antibodies

#690
20110280899
2011-11-17

Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopes

#691
20110274720
2011-11-10

Capsular gram-positive bacteria bioconjugate vaccines

#692
20110274717
2011-11-10

Polysaccharide conjugation with detoxified heat labile enterotoxin (LT) used as vaccine

#693
20110268743
2011-11-03

Probiotics, secretory IgA and inflammation

#694
20110268670
2011-11-03

Synthetic peptide constructs for the diagnosis and treatment of Periodontitis associated with

#695
20110262526
2011-10-27

METHOD OF INDUCING AN ANTI-VIRAL IMMUNE RESPONSE

#696
20110250196
2011-10-13

Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogen

#697
20110236414
2011-09-29

Bacterial Polysaccharide-Polypeptide Conjugate Compositions

#698
20110229513
2011-09-22

LPS Based Vaccines

#699
20110229512
2011-09-22

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING URINARY TRACT INFECTIONS

#700
20110217329
2011-09-08

Vaccine

#701
20110217320
2011-09-08

HAPTEN-CARRIER CONJUGATES FOR TREATING AND PREVENTING NICOTINE ADDICTION

#702
20110217312
2011-09-08

Targeting poly-γ-glutamic acid to treat and related infections

#703
20110217307
2011-09-08

Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies

#704
20110212125
2011-09-01

Vaccine for shigella

#705
20110212124
2011-09-01

Vaccine Composition

#706
20110206758
2011-08-25

Vaccine compositions comprising a saponin adjuvant

#707
20110206742
2011-08-25

Immunotherapeutic compositions for the treatment of alzheimer'S disease

#708
20110201791
2011-08-18

MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION

#709
20110195086
2011-08-11

15-valent pneumococcal polysaccharide-protein conjugate vaccine composition

#710
20110182893
2011-07-28

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES

#711
20110177066
2011-07-21

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES

#712
20110172393
2011-07-14

NOVEL FORMULATIONS WHICH STABILIZE AND INHIBIT PRECIPITATION OF IMMUNOGENIC COMPOSITIONS

#713
20110171244
2011-07-14

Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof

#714
20110165191
2011-07-07

Tat DNA sequences, gene constructs, vaccine and processes thereof

#715
20110159030
2011-06-30

MUCOSAL COMBINATION VACCINES FOR BACTERIAL MENINGITIS

#716
20110159028
2011-06-30

Compositions and methods for diagnosing and treating urinary tract infections

#717
20110150923
2011-06-23

MUCOSAL MENINGOCOCCAL VACCINES

#718
20110150880
2011-06-23

Methods and compositions relating to synthetic β-1,6 glucosamine oligosaccharides

#719
20110117128
2011-05-19

Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof

#720
20110117123
2011-05-19

Multivalent vaccine composition with mixed carrier

#721
20110110967
2011-05-12

GAS57 mutant antigens and GAS57 antibodies

#722
20110097357
2011-04-28

Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells

#723
20110071279
2011-03-24

Multivalent pneumococcal polysaccharide-protein conjugate composition

#724
20110070259
2011-03-24

Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine

#725
20110064734
2011-03-17

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

#726
20110059120
2011-03-10

Glucan-based vaccines

#727
20110052624
2011-03-03

Type 5 and type 8 capsular polysaccharides of overproducing strains

#728
20110045017
2011-02-24

HIV VACCINE FOR MUCOSAL DELIVERY

#729
20110045015
2011-02-24

Conjugated beta-1,3-linked glucans

#730
20110027311
2011-02-03

Combination of protein vaccine and mesenchymal stem cells for treating cancer

#731
20110020392
2011-01-27

PROCESS FOR TREATMENT OF RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

#732
20110002957
2011-01-06

Hapten-carrier conjugates for treating and preventing nicotine addiction

#733
20100330117
2010-12-30

PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS, NON-VIRAL BASED CANCERS, ALZHEIMERS'S DISEASE, MUSCULAR DYSTROPHY, ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER, COMPLEX REGIONAL PAIN SYNDROME, DIABETES, NEUROPATHIC PAIN, SPIDER ARTHRITIS, WEST NILE VIRUS, FIBROMYALGIA, SHINGLES, GOUT, MIGRAINE HEADACHES, SENILE DEMENTIA, POST POLIO SYNDROME, CENTRAL VIRUS DEAFNESS, ASTHMA, CHRONIC PAIN OF UNKNOWN ORIGIN AND HEPATITIS C

#734
20100330105
2010-12-30

Anticancer Combination Therapies

#735
20100322959
2010-12-23

Immunogenic composition

#736
20100322958
2010-12-23

Modified saccharides

#737
20100316666
2010-12-16

Multivalent pneumococcal polysaccharide-protein conjugate composition

#738
20100316663
2010-12-16

Subunit vaccine for aquaculture

#739
20100311105
2010-12-09

Methods of delivery of exogenous proteins to the cytosol and uses thereof

#740
20100310594
2010-12-09

RECOMBINANT ADENYLATE CYCLASE TOXIN OF BORDETELLA INDUCES T CELL RESPONSES AGAINST TUMORAL ANTIGENS

#741
20100303852
2010-12-02

Conjugation process for PNAG and a carrier protein

#742
20100297166
2010-11-25

Meningococcal oligosaccharide linked polysaccharides and diptheria protein conjugate vaccine for all ages

#743
20100291138
2010-11-18

Vaccine

#744
20100267617
2010-10-21

Methods and compositions for exotoxins

#745
20100266672
2010-10-21

VACCINES

#746
20100266626
2010-10-21

ADJUVANTED GLUCANS

#747
20100260762
2010-10-14

De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy

#748
20100253934
2010-10-07

Analysis of mixtures including proteins

#749
20100240575
2010-09-23

Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same

#750
20100239604
2010-09-23

Vaccine comprising capsular polysaccharide conjugates

#751
20100239601
2010-09-23

Method of immunizing humans against using a Vi-EPA conjugate vaccine

#752
20100239600
2010-09-23

Conjugate purification

#753
20100233201
2010-09-16

Polyanionic polymer adjuvants for B saccharide vaccines

#754
20100215686
2010-08-26

Process for manufacturing vaccines

#755
20100215685
2010-08-26

Acyl pseudodipeptides which carry a functionalized auxiliary arm

#756
20100209450
2010-08-19

Vaccine comprising capsular polysaccharide conjugates

#757
20100209449
2010-08-19

HAPTEN-CARRIER CONJUGATES FOR USE IN DRUG-ABUSE THERAPY AND METHODS FOR PREPARATION OF SAME

#758
20100203136
2010-08-12

METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (Hcg) VACCINE FOR LONG-ACTING ANTIBODY PROTECTION

#759
20100196451
2010-08-05

Vaccines Containing Non-Live Antigenic Vectors

#760
20100196421
2010-08-05

Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof

#761
20100196418
2010-08-05

Universal carrier for targeting molecules to Gb3 receptor expressing cells

#762
20100196417
2010-08-05

Compositions comprising a B subunit of Shiga toxin and a means stimulating NKT cells

#763
20100189740
2010-07-29

MODIFIED POLYSACCHARIDES FOR CONJUGATE VACCINES

#764
20100183662
2010-07-22

VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES

#765
20100150954
2010-06-17

Vaccines against influenza virus

#766
20100143399
2010-06-10

Process for manufacturing vaccines

#767
20100136045
2010-06-03

protein antigens and methods

#768
20100136042
2010-06-03

Globo H and related anti-cancer vaccines with novel glycolipid adjuvants

#769
20100136041
2010-06-03

COMBINATION GAS VACCINES AND THERAPEUTICS

#770
20100129382
2010-05-27

Combination therapy for the treatment of tumors

#771
20100124556
2010-05-20

protein antigens and methods

#772
20100119544
2010-05-13

Vaccine

#773
20100112071
2010-05-06

Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein

#774
20100105672
2010-04-29

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

#775
20100104593
2010-04-29

Meningococcal conjugate vaccination

#776
20100092524
2010-04-15

Modification of exosomal components for use as a vaccine

#777
20100092509
2010-04-15

Hypo- and Hyper- Acetylated Meningococcal Capsular Saccharides

#778
20100080826
2010-04-01

PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

#779
20100074922
2010-03-25

Pneumococcal polysaccharide conjugate vaccine

#780
20100074918
2010-03-25

VACCINE

#781
20100068728
2010-03-18

POLYSACCHARIDE DERIVATIVES AND USES IN INDUCTION OF AN IMMUNE RESPONSE

#782
20100068222
2010-03-18

Hapten-carrier conjugates for use in drug abuse therapy and methods for preparation of same

#783
20100062023
2010-03-11

CHOLESTEROL-CONTAINING COMPOUNDS AND THEIR USE AS IMMUNOGENS AGAINST BORRELIA BURGDORFERI

#784
20100062011
2010-03-11

Peptide vaccine for inducing the production of anti-amyloid β-peptide antibody

#785
20100047262
2010-02-25

Amyloid-beta polypeptide vaccine

#786
20100040644
2010-02-18

Methods for preparing immunogenic conjugates

#787
20100034825
2010-02-11

Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies

#788
20100021503
2010-01-28

IMMUNOGENIC COMPOSITION

#789
20100015172
2010-01-21

Method to reduce the physiologic effects of drugs on mammals

#790
20100008980
2010-01-14

Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of Cancer

#791
20090324639
2009-12-31

COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY

#792
20090318337
2009-12-24

Compositions and methods for activating innate and allergic immunity

#793
20090317411
2009-12-24

COMPOSITIONS FOR INDUCING IMMUNE RESPONSES SPECIFIC TO GLOBO H AND SSEA3 AND USES THEREOF IN CANCER TREATMENT

#794
20090311285
2009-12-17

VACCINE

#795
20090311281
2009-12-17

NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID

#796
20090297593
2009-12-03

Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment

#797
20090297511
2009-12-03

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

#798
20090291098
2009-11-26

Immunogenic LHRH compositions and methods relating thereto

#799
20090285822
2009-11-19

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

#800
20090285809
2009-11-19

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES

#801
20090280125
2009-11-12

Prion epitopes and methods of use thereof

#802
20090269364
2009-10-29

HER-2/NEU MULTI-PEPTIDE VACCINE

#803
20090258397
2009-10-15

METHOD OF PRODUCING MENINGOCOCCAL MENINGITIS VACCINE FOR NEISSERIA MENINGITIDIS SEROTYPES A, C, Y, and W-135

#804
20090252759
2009-10-08

Immunogenic composition

#805
20090234108
2009-09-17

MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION

#806
20090232894
2009-09-17

Process for stabilizing an adjuvant containing vaccine composition

#807
20090232840
2009-09-17

Vaccines against O157 infection

#808
20090226484
2009-09-10

Immunogenic LHRH compositions and methods relating thereto

#809
20090214586
2009-08-27

Combination vaccines with whole cell pertussis antigen

#810
20090214438
2009-08-27

METHODS AND COMPOSITIONS FOR THE PREPARATION AND USE OF TOXIN CONJUGATES

#811
20090196886
2009-08-06

VACCINE AGAINST NICOTINE ADDICTION

#812
20090191232
2009-07-30

Combination therapy for the treatment of tumors

#813
20090191231
2009-07-30

Prevention and treatment of amyloidogenic disease

#814
20090182129
2009-07-16

Capsular polysaccharide solubilisation and combination vaccines

#815
20090182128
2009-07-16

Capsular polysaccharide solubilisation and combination vaccines

#816
20090181054
2009-07-16

Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine

#817
20090181053
2009-07-16

Capsular polysaccharide solubilisation and combination vaccines

#818
20090181049
2009-07-16

Capsular polysaccharide solubilisation and combination vaccines

#819
20090176311
2009-07-09

SEPARATION OF CONJUGATED AND UNCONJUGATED COMPONENTS

#820
20090162400
2009-06-25

Compositions of influenza viral proteins and methods of use thereof

#821
20090155305
2009-06-18

Manufacture of Vaccines That Contain Both Hepatitis B Virus Surface Antigen and Surfactant

#822
20090155297
2009-06-18

Methods and Compositions for Inducing an Immune Response Against Multiple Antigens

#823
20090136567
2009-05-28

Adhesin-enterotoxin chimera based immunongenic composition against enterotoxigenic

#824
20090136541
2009-05-28

Immunogenic composition

#825
20090136535
2009-05-28

Adjuvant activities of mutants of LT-IIa and LT-IIb enterotoxin lacking binding to ganglioside

#826
20090130147
2009-05-21

Capsular polysaccharide solubilisation and combination vaccines

#827
20090130140
2009-05-21

Capsular polysaccharide solubilisation and combination vaccines

#828
20090130137
2009-05-21

Multivalent pneumococcal polysaccharide-protein conjugate composition

#829
20090117148
2009-05-07

Capsular polysaccharides solubilisation and combination vaccines

#830
20090117145
2009-05-07

Composition and method for enhancing immune response

#831
20090117143
2009-05-07

Recombinant adenylate cyclase toxin of induces T cell responses against tumoral antigens

#832
20090104268
2009-04-23

Nanoparticles comprising antigens and adjuvants, and immunogenic structures

#833
20090092632
2009-04-09

Methods for preparing complex multivalent immunogenic conjugates

#834
20090092579
2009-04-09

NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID

#835
20090081256
2009-03-26

TRANSGENIC PLANT-BASED VACCINES

#836
20090081254
2009-03-26

HIV VACCINE FOR MUCOSAL DELIVERY

#837
20090081202
2009-03-26

Immunogenic compositions and methods

#838
20090069544
2009-03-12

Humanized antibodies that recognize beta amyloid peptide

#839
20090068220
2009-03-12

Compositions and methods for diagnosing and treating urinary tract infections

#840
20090060945
2009-03-05

Integration of meningococcal conjugate vaccination

#841
20090053248
2009-02-26

Compositions and methods for transepithelial molecular transport

#842
20090053235
2009-02-26

Use of alpha-toxin for treating and preventing staphylococcus infections

#843
20090047303
2009-02-19

Method for improving the immunogenicity of plasmodium antigens

#844
20090043077
2009-02-12

Conjugation of streptococcal capsular saccharides

#845
20090041802
2009-02-12

Immunogenic composition

#846
20090028909
2009-01-29

Intranasal vaccine for use against disease caused by enterotoxigenic

#847
20090017072
2009-01-15

Vaccine

#848
20090017060
2009-01-15

Cleavable vaccine compositions and uses thereof and methods of making and using the same

#849
20090017059
2009-01-15

Vaccine Comprising Streptococcus Pneumoniae Capsular Polysaccharide Conjugates

#850
20090017056
2009-01-15

SKIN IMMUNIZATION USING LT-STA FUSION PROTEINS

#851
20090010959
2009-01-08

Pneumococcal Polysaccharide Conjugate Vaccine

#852
20090010944
2009-01-08

Oligosialic acid derivatives, methods of manufacture, and immunological uses

#853
20090004223
2009-01-01

Capsule composition for use as immunogen against

#854
20090004200
2009-01-01

Combination treatment of pancreatic cancer

#855
20080318285
2008-12-25

METHOD OF PRODUCING MENINGOCOCCAL MENINGITIS VACCINE FOR NEISSERIA MENINGITIDIS SEROTYPES A, C, Y, and W-135

#856
20080317775
2008-12-25

Enzymatic degradation of lipid A fatty acids of bacterial LPS

#857
20080305127
2008-12-11

Conjugate Vaccines

#858
20080305125
2008-12-11

Mutant forms of EtxB and CtxB and their use as carriers

#859
20080281082
2008-11-13

HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE

#860
20080279926
2008-11-13

Vaccine Compositions Comprising a Saponin Adjuvant

#861
20080274143
2008-11-06

Chloroplasts Engineering to Express Pharmaceutical Proteins

#862
20080274126
2008-11-06

Oral Vaccines for Fish

#863
20080260773
2008-10-23

Saccharide Conjugate Vaccines

#864
20080254057
2008-10-16

Combined meningococcal conjugates with common carrier protein

#865
20080253993
2008-10-16

Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope

#866
20080248029
2008-10-09

Prevention and treatment of amyloidogenic diseases

#867
20080248023
2008-10-09

Prevention and treatment of amyloidogenic diseases

#868
20080247994
2008-10-09

DNA vaccine

#869
20080241183
2008-10-02

Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction

#870
20080241180
2008-10-02

Liquid vaccines for multiple meningococcal serogroups

#871
20080227719
2008-09-18

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

#872
20080227718
2008-09-18

Prevention and treatment of amyloidogenic disease

#873
20080221306
2008-09-11

Humanized antibodies that recognize beta amyloid peptide

#874
20080206276
2008-08-28

Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections

#875
20080199490
2008-08-21

Immunogenic composition

#876
20080199487
2008-08-21

Glycosylceramide adjuvant for saccharide antigens

#877
20080193481
2008-08-14

Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines

#878
20080193476
2008-08-14

Immunogenic composition

#879
20080131457
2008-06-05

Use of alpha-toxin for treating and preventing staphylococcus infections

#880
20080124284
2008-05-29

Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with

#881
20080112951
2008-05-15

Glycoconjugates and their use as potential vaccines against infection by

#882
20080107653
2008-05-08

Hybrid Shiga-like toxin

#883
20080096818
2008-04-24

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

#884
20080095803
2008-04-24

Protein matrix vaccines and methods of making and administering such vaccines

#885
20080069835
2008-03-20

VACCINE COMPOSITION

#886
20080069832
2008-03-20

Vaccines

#887
20080063660
2008-03-13

Method to reduce the physiologic effects of drugs on mammals

#888
20080050367
2008-02-28

Humanized antibodies that recognize beta amyloid peptide

#889
20080038291
2008-02-14

Method to reduce the physiologic effects of drugs on mammals

#890
20080026000
2008-01-31

Hapten-carrier conjugates for treating and preventing nicotine addiction

#891
20080020428
2008-01-24

Method of producing meningococcal meningitis vaccine for serotypes A,C,Y, and W-135

#892
20080020002
2008-01-24

METHOD OF PRODUCING MENINGOCOCCAL MENINGITIS VACCINE FOR NEISSERIA MENINGITIDIS SERO TYPES A,C,Y, and W-135

#893
20080019992
2008-01-24

Antigen mimotopes and vaccine against cancerous diseases

#894
20080019988
2008-01-24

Targeting of genetic vaccine vectors

#895
20080019983
2008-01-24

Method of protecting against staphylococcal infection

#896
20080008722
2008-01-10

Fusion protein of porcine reproductive and respiratory syndrome virus as PRRS vaccine

#897
20080008709
2008-01-10

Conjugation of biomolecules using Diels-Alder cycloaddition

#898
20070286871
2007-12-13

Vaccines

#899
20070264280
2007-11-15

Compositions and Methods for Treating Neurological Diseases

#900
20070253985
2007-11-01

NOVEL PROCESSES FOR COATING CONTAINER MEANS WHICH INHIBIT PRECIPITATION OF POLYSACCHARIDE-PROTEIN CONJUGATE FORMULATIONS